Abbvie, US reach agreement to cut drug prices
Jan 12 (Reuters) - Abbvie reached a three-year agreement with U.S. President Donald Trump's administration to provide low prices in Medicaid through TrumpRx, and pledged $100 billion over the next decade for research and development in the U.S., the company said on Monday.
(Reporting by Ruchika Khanna in Bengaluru; Editing by Chris Reese)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Stop calling everything a “stablecoin” | Opinion
Italy launches probe into Activision Blizzard over promotion of in-game purchases
US Homebuilder Confidence Declines at the Beginning of 2026
The 6000x Signal: Why Smart Money is Dumping Blazpay & Maxi Doge for Zero Knowledge Proof
Trending news
MoreCrypto prices
More
